Drugs / RANCAD
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT02294942 | Oct 2014 → Dec 2016 | — | TSH Biopharm Corporation Limited | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | RANCAD | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02294942 ↗ |